Physician's Weekly Podcast Physician's Weekly

Board-certified radiologist, medical malpractice lawyer, and regular contributor Dr. MedLaw talks about how doctors should approach the situation when patients want to take charge of their treatment plan entirely, without considering all the evidence-based options. Also, Jaime Herrera Caceres, MD (Penn State Health), briefly discusses a novel stent methodology for male incontinence, recently in the news, as well as his important work galvanizing the local LatinX medical community to give public lectures in Spanish on preventative medicine and cultural stigmas to raise health literacy and awareness. 

Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!
Thanks for listening!

Joseph Vassalotti, MD (Clinical Professor of Nephrology at Icahn School of Medicine at Mount Sinai and CMO at the National Kidney Foundation), talks about how doctors should properly test for renal function using a race-independent equation, about albuminuria, and about the effects of COVID-19 on patient’s kidneys. Also, Jeremy Reiter, MD, PhD (Professor at UCSF), discusses the underpinnings of kidney diseases, both sporadic and inherited, as well as the Tabula Sapiens project in which his lab contributed in-depth transcriptome data from various sites along the nephron. 

Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!
Thanks for listening!

We talked on the street outside ASCO GU 2023 with kidney cancer survivors and advocates Bryan Lewis and Howard McClurd of KidneyCan about how they helped raise $235 million in 6 years for kidney cancer research. KidneyCan runs the Kidney Cancer Advocacy Days, for which they encourage all stakeholders to join meetings in Washington, DC on March 13 and virtual meetings conducted via Zoom on March 14. Also, Michael Alchoueiry, MD (Brigham and Woman’s Hospital), talks about his work on the unique pathophysiology of chromophobe renal cell carcinoma, the unmet need in patients for targeted therapies, and about his group’s recent publication looking at ferroptosis as the potential Achilles heel for this type of tumor. 

Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!
Thanks for listening!

Toni Choueiri, MD (Dana-Farber Cancer Institute, Harvard), discusses the latest research in kidney cancer presented at the 2023 ASCO Genitourinary Cancers Symposium. Also, regular contributor Dr. MedLaw explains all you need to consider and do, as well as not do, in the delicate situation of having to report a colleague.

Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!
Thanks for listening!

PW Editorial Board Member Alex McDonald, MD, talks with Hussain Lalani, MD, MPH ( Brigham and Women’s Hospital, Harvard Medical School), who’s research focuses on understanding the challenges and inequities patients face in accessing affordable prescription drugs and evaluating the impact of health policies and interventions. He also serves on the National Steering Committee of Doctors for America’s Drug Affordability Action Team. They talk about what all doctors in the US should know about pharmaceutical pricing, and the implications that process can have.  Also, Matthias Stelljes, MD (University of Muenster, Germany), discusses the outcomes and implications of the ASAP trial, which assessed the management of relapsed or refractory acute myeloid leukemia using intensive chemotherapy in advance of allogeneic hematopoietic cell transplantation.

Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!
Thanks for listening!

Kai Rejeski, MD, (University Hospital, LMU Munich, Germany) discusses CAR-T cell therapy in mantle cell lymphoma and beyond, including the new tool he and colleagues have developed that can predict toxicity, infections, and clinical outcomes. Also, regular contributor Dr. MedLaw explains what kind of liability exists when a doctor recommends another doctor to a hospital or practice. It turns out that failure to honestly describe a candidate for a job can carry significant liability.

Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!
Thanks for listening!